A comparative study of the reversal by different α2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 587-593

  Vayssettes Courchay, Christine ^a   Bouysset, Françoise ^a   Cordi, Alex A ^a   Laubie, Michel ^a   Verbeuren, Tony J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Blood pressure; Clonidine; Sympathetic nerve activity; adrenoceptor

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; CLONIDINE; FLUPAROXAN; IDAZOXAN; IMIDAZOLINE DERIVATIVE; PRAZOSIN; YOHIMBINE;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG STRUCTURE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY NERVE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

EID: 0030049001     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15231.x     Document Type: Article

References (47)

1. BLAXALL, H.S., MURPHY, T.J., BAKER, J.C., RAY, C. & BYLUND, D.B. (1991). Characterization of the alpha-2C adrenergic receptor subtype in the oppossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther., 259,1, 323-329.
2. BORKOWSKI, K.R. & FINCH, L. (1979). A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anaesthetized rat. J. Pharmacol., 31, 16-19.
3. BOUSQUET, P., FELDMAN, J., BLOCK, R. & SCHWARTZ, J. (1981). The nucleus reticularis lateralis: a region highly sensitive to clonidine. Eur. J. Pharmacol., 69, 389-392.
4. BOUSQUET, P., FELDMAN, J & SCHWARTZ, J. (1984). Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232-236.
5. 2-Adrenoceptors subtypes and imidazoline-like binding sites in rat brain. Br. J. Pharmacol., 99, 803-809.
6. BYLUND, D.B. (1985). Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav., 22, 835-843.
7. BYLUND, D.B., BLAXALL, H.S., MURPHY, T.J. & SIMMONEAUX, V. (1991). Pharmacological evidence for alpha-2C and alpha-2D adrenergic receptor subtypes. In Adrenoceptors: Structure, Mechanisms, Function. ed. Szabadi E & Bradshaw C.M. pp 27-36. Adv. Pharmacol. Sci., Basel: Birkhauser.
8. BYLUND, D.B., EIKENBERG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLO, R.R. & TRENDELENBURG, U. (1995). International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol. Rev., 46, 121-136.
9. BYLUND, D.B., RAY-PRENGER, C. & MURPHY, T.J. (1988). Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther., 245, 600-607.
10. CACECI, M.S. & CACHERIS, W.P. (1984). Fitting curves to data: the Simplex algorithm is the answer. Byte, may, 340-362.
11. 2-adrenoceptor antagonism. Br. J. Pharmacol., 80, 128P.
12. 2-adrenoceptors. Br. J. Pharmacol., 78, 489-505.
13. DREW, G.M. (1976). Effects of α-adrenoceptor agonists and antagonists on pre- and postsynaptically located α-adrenoceptors. Eur. J. Pharmacol., 36, 313-320.
14. ERNSBERGER, P., GIULIANO, R., WILLETTE, R.N., GRANATA, A.R. & REIS, D.J. (1988). Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J. Hypertens., 6, S554.
15. ERNSBERGER, P., GIULIANO, R., WILLETTE, N. & REIS, D.J. (1990). Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther., 253, 408-418.
16. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol., 134, 1-13.
17. GUTKIND, J.S., KAZANIETZ, M. & ENERO, M.A. (1986). Cardiovascular effects of alpha-adrenergic drugs: Differences between clonidine and guanabenz. Naunyn Schmied. Arch. Pharmacol., 332, 370-375.
18. 2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotoninergic neurons innervating spinal cord. Brain Res., 638, 285-294.
19. 3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur. J. Pharmacol., 146, 345-348.
20. 2-adrenergic receptors. Mol. Pharmacol., 40, 407-412.
21. HEAD, G.A., GOODWlN, S.J. & SANNAJUST, F. (1993). Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J. Hypertension, 11, S2.
22. 2-adrenoceptors. Br. J. Pharmacol., 110, 1635-1639.
23. 2-adrenoceptors. Br. J. Pharmacol., 100, 345P.
24. KARPPANEN, H. (1981). Interrelationships between clonidine and histaminergic mechanisms. Trends Pharmacol. Sci., 2, 35-37.
25. 2A-adrenoceptors. Eur. J. Pharmacol., 167, 95-104.
26. 2-adrenergic binding sites. Mol. Pharmacol., 37, 876-885.
27. LAUBIE, M., DELBARRE, B., BOGAIEVSKY, D., BOGAIEVSKY, Y., TSOUCARIS-KUPPER, D., SENON, D. & SCHMITT, H. (1976). Pharmacological evidence for a central-sympathomimetic mechanism controlling blood pressure and heart rate. Circ. Res., Suppl II, 6, 35-41.
28. 2-C10 homolog responsible of an interspecies variation in antagonist binding. Mol. Pharmacol., 42, 16-27.
29. MALLARD, N.J., HUDSON, A.L. & NUTT, D.J. (1992). Characterization and autoradiographical localization of non-adrenergic idazoxan binding sites in the rat brain. Br. J. Pharmacol., 106, 1019-1027.
30. 3H]RX821002 in the rat brain. Br. J. Pharmacol., 102, 221P.
31. MICHEL, M.C. & ERNSBERGER, P. (1992). Keeping an eye on the I sile: Imidazoline-preferring receptors. Trends Pharmacol. Sci., 13, 369-370.
32. MICHEL, M.C. & INSEL, P.A. (1989). Are there multiple imidazoline binding site? Trends Pharmacol. Sci., 10, 342-344.
33. 2-adrenoceptor. Clin. Sci., 68, 29s-42s.
34. 2-adrenoceptor antagonists in the pithed rat preparation. Br. J. Pharmacol., 79, 012-014.
35. 2-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neurosci., 56, 139-155.
36. SCHMITT, H. (1977). The pharmacology of clonidine and related products. in Handbook of Experimental Pharamacology. ed. Gross F., p 299. Berlin: Springer-Verlag.
37. SCHMITT, H., SCHMITT, H. & FENARD, S. (1973). Action of α-adrenergic blocking drugs on the sympathetic centers and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneim. Forsch., 23, 40-43.
38. SHEPPERSON, N.B., DUVAL, N., MASSINGHAM, R. & LANGER, S.Z. (1981). Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastercomers rauwolscine and corynanthine in the anesthetized dog. J. Pharmacol. Exp. Ther., 219, 540-546.
39. SUN, M.K. & GUYENET, P.G. (1986), Effect of clonidine and γ-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Res., 368, 1-17.
40. TIMMERMANS, P.B.M.W.M., SCHOOP, A.M.C., KWA, H.Y. & VAN ZWIETEN, P.A. (1981). Characterization of α-adrenoceptors participating in the central hypotensive and selective effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur. J. Pharmacol., 70, 7-15.
41. 2-adrenoceptors in the rat kidney. Br. J. Pharmacol., 104, 657-664.
42. 2-adrenoceptor. Br. J. Pharmacol., 106, 986-995.
43. 3 receptors in anaesthetized rats. Eur. J. Pharmacol., 184, 75-85.
44. VAYSSETTES-COURCHAY, C., BOUYSSET, H., VERBEUREN, T.J. & LAUBIE, M. (1993). Role of the lateral tegmental field in the central sympatho-inhibitory effect of 8-hydroxy-2-(di-n-propylamino)tetralin in the cat. Eur. J. Pharmacol., 236, 121-130.
45. WIKBERG, J.E.S. (1989). High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan receptor. Pharmacol. Toxicol., 69, 152-155.
46. WIKBERG, J.H.S., UHLEN, S. & CHHAJLANI, V. (1991). Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea-pig. Eur. J. Pharmacol., 193, 335-340.
47. 2B-adrenoceptor subtypes. Eur. J. Pharmacol., 168, 381-386.